RECENT NEWS
TechCrunch  4 hrs ago  Comment 
 International VC firm SOSVentures is capitalizing on the now buzz worthy biotech investment trend with the creation of IndieBio, the first accelerator to focus on just life sciences. Y Combinator raised a few eyebrows when it accepted five...
MarketWatch  9 hrs ago  Comment 
Shares of biotechnology giant Biogen Idec Inc. tumble after it’s revealed a patient using its multiple-sclerosis drug Tecfidera has died.
Wall Street Journal  10 hrs ago  Comment 
Concerns about the potential side effects of Biogen Idec’s key multiple-sclerosis treatment Tecfidera overshadowed the strong third-quarter results the biotech company posted Wednesday.
Motley Fool  11 hrs ago  Comment 
These three biotech companies may benefit if short sellers reverse course.
StreetInsider.com  12 hrs ago  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/iBio%2C+Inc.+%28IBIO%29%2C+Novici+Biotech+Expand+Collaboration+to+Include+IBIO-CFB03/9930934.html for the full story.
Motley Fool  12 hrs ago  Comment 
Biotech stocks running out of money is a common concern for investors of clinical-stage and early commercial stage stocks. Let's take a closer look at Arena Pharmaceuticals' current cash situation and determine whether or not current investors...
Market Intelligence Center  Oct 22  Comment 
After Tuesday's trading in Biotech Holders (BBH) the option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center uncovered a trade that offers a 3.33% return, or 20.61% annualized (for comparison...
StreetInsider.com  Oct 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+Biotech+%28GNBT%29+Unit+Publishes+White+Paper+Promoting+Ii-Key+in+Ebola+Vaccine+Development/9927113.html for the full story.
Market Intelligence Center  Oct 21  Comment 
After Monday's trading in Biotech Holders (BBH) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 3.69% or 22.48% (for comparison purposes only), while providing 4.15% downside...
Wall Street Journal  Oct 21  Comment 
Strong sales of a new drug helped push Actelion’s earnings higher in the third quarter, prompting Europe’s biggest biotech to upgrade its full-year guidance.




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors




Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share

References

  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009 http://knol.google.com/k/top-ten-twenty-best-selling-drugs-2009#

M&A Biotechnology http://knol.google.com/k/m-a-biotechnology#

http://knol.google.com/k/biotechnology-market-review-top-ten-biologics-2009#

Monoclonal Antibody Market 2009 http://knol.google.com/k/-/monoclonal-antibody-market-2009/3fy5eowy8suq3/86#

http://knol.google.com/k/new-drug-approvals-usa-fda-2009#

http://knol.google.com/k/new-drug-approvals-europe-ema-2009#

Vaccine Market 2009 http://knol.google.com/k/-/vaccine-market-2009/3fy5eowy8suq3/104#

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs) http://knol.google.com/k/global-monoclonal-antibodies-market-review-2008-world-top-ten-mabs#

M&A Review: Pharmaceutical & Biotechnology Industry http://knol.google.com/k/m-a-review-pharmaceutical-biotechnology-industry#

Global Vaccine Market Review 2008 (World Top Ten Vaccines) http://knol.google.com/k/global-vaccine-market-review-2008-world-top-ten-vaccines#


Ipilimumab (BMS) Review: A Cancer Breakthrough? http://knol.google.com/k/-/ipilimumab-bms-review-a-cancer/3fy5eowy8suq3/107#

Denosumab (Prolia, Amgen) FDA Review & Approval http://knol.google.com/k/-/denosumab-prolia-amgen-fda-review/3fy5eowy8suq3/60#

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki